Home  >  Products  >  CCNB2 (cyclin B2 ) Blocking Peptide (the C terminal of CCNB2)(100ug)
CCNB2 (cyclin B2 ) Blocking Peptide (the C terminal of CCNB2)(100ug)

CCNB2 (cyclin B2 ) Blocking Peptide (the C terminal of CCNB2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CCNB2 Antibody (ARP63411_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63411
Size: 100ug
Weight: 44kDa
Gene: 9133
Format: Lyophilized powder
Target: Cyclin B2 is a member of the cyclin family, specifically the B-type cyclins. The B-type cyclins, B1 and B2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery. B1 and B2 differ in their subcellular localization. Cyclin B1 co-localizes with microtubules, whereas cyclin B2 is primarily associated with the Golgi region. Cyclin B2 also binds to transforming growth factor beta RII and thus cyclin B2/cdc2 may play a key role in transforming growth factor beta-mediated cell cycle control.
Alternative names: HsT17299
See Full Product Listings >